最近和先进的纳米技术策略用于COVID-19疫苗开发
Chinekwu Sherridan Nwagwu1, Chinenye Nnenna Ugwu2, John Dike Nwabueze Ogbonna1
1Drug Delivery & Nanomedicines Research Laboratory, Department of Pharmaceutics, University of Nigeria, Nsukka, Enugu State, Nigeria.
Methods in microbiology
|April 15, 2024
概括
纳米技术为开发有效的COVID-19疫苗提供了有希望的战略. 本文重点介绍了当前纳米技术在疫苗设计中所采用的方法,以控制疫情.
科学领域:
- * 传染病和病毒学
- * 纳米技术和疫苗开发
背景情况:
- *由SARS-CoV-2引起的COVID-19大流行,对全球健康构成了重大挑战.
- *非药物干预已减缓但没有消除病毒传播.
- *变种的出现需要快速开发安全有效的疫苗.
研究的目的:
- * 审查目前用于COVID-19疫苗开发的纳米技术战略.
- * 突出纳米技术在提高疫苗有效性和发放中的作用.
主要方法:
- * 关于纳米技术在COVID-19疫苗开发中的研究的综合文献综述.
- *分析纳米大小的材料,用于抗原输送系统和辅助剂.
主要成果:
- *纳米材料显示出在候选疫苗中安全有效的抗原传递的潜力.
- *纳米技术可以增强免疫反应,提高疫苗的有效性.
- * 几种基于纳米技术的COVID-19疫苗候选人在开发的各个阶段.
结论:
- *纳米技术是推动开发下一代COVID-19疫苗的关键工具.
- * 对纳米疫苗的持续研究对于全球流行病的准备和控制至关重要.
关键词:
在 COVID-19 疫情中,关于COVID-19疫苗的使用情况豁免权是一种豁免权.纳米载体的使用方法纳米颗粒 疫苗辅助剂 纳米颗粒纳米技术 纳米技术这是一个RNARNARNARNARNA.这就是SARS-COV-2病毒.更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.5K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.6K
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
